… vity to the active substance, or to any of the excipients listed in section 6.1
• cardiogenic shock
• uncontrolled heart failure
• sick sinus syndrome
• second-or third-degree heart block
• untreated phaeochromocytoma
• metabolic acidosis
• bradycardia (<45 bpm)
• hypotension
• severe peripheral arterial circulatory disturbances.
Identical in all 8 labels. Surrounding text shown from Aurobindo Pharma - Milpharm Ltd..
… or to any of the excipients listed in section 6.1.
- Second or third-degree heart block.
- Cardiogenic shock.
- Uncontrolled heart failure.
- Sick sinus syndrome (including sino-atrial block).
- Untreated phaeochromocytoma.
- Metabolic acidosis
- Bradycardia (less than 45-50 beats per minute)
- Hypotension
- Severe peripheral circulatory disturbances
- Concomitant intravenous use of verapamil or diltiazem
- Severe …